The nation’s pharmaceutical companies appear ready to swallow up the so-called doughnut hole, the gap between Medicare Part D coverage and access to additional coverage options for prescription drugs.
Four weeks after pledging $2 trillion in savings over the next decade for health care in the United States, six stakeholders presented a cost containment plan to President Barack Obama.
As a direct result of the Patient Protection and Affordable Care Act (PPACA) – also known as ObamaCare – health insurance agent and broker commissions have been slashed by as much as 50%. Agencies have been forced to lay off employees, limit products and services, shift to other lines, and have seen significant drops in compensation.